Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt

International Journal of Oncology

Volumn 40, Issue 5, 2012, Pages 1697-1704

  Jeong, Jin Woo ^a,b   Jin, Cheng Yun ^c   Park, Cheol ^a,c   Han, Min Ho ^c   Kim, Gi Young ^d   Moon, Sung Kwon ^e   Kim, Chan Gil ^f   Jeong, Yong Kee ^g   Kim, Wun Jae ^h   Lee, Jae Dong ^b   Choi, Yung Hyun ^a,c  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Jeju National University   (South Korea)

^e Chungju National University   (South Korea)

^f Konkuk University   (South Korea)

^g Dong A University   (South Korea)

^h Chungbuk National University College of Medicine   (South Korea)

Author keywords

Cordycepin; Invasion; Matrix metalloproteinases; PI3K Akt; Tight junctions

Indexed keywords

CLAUDIN; CORDYCEPIN; GELATINASE A; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN LNCAP; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INTRACELLULAR TRANSPORT; MIGRATION INHIBITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TIGHT JUNCTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CLAUDINS; DEOXYADENOSINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84860289112     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1332     Document Type: Article

References (41)

1. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM and Mullin JM: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20: 1425-1431, 1999. (Pubitemid 29385425)
2. Schneeberger EE and Lynch RD: The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-C1228, 2004. (Pubitemid 38649971)
3. Furuse M, Furuse K, Sasaki H and Tsukita S: Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263-272, 2001. (Pubitemid 34280213)
4. Rubenwolf P and Southgate J: Permeability of differentiated human urothelium in vitro. Methods Mol Biol 763: 207-222, 2011.
5. Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606, 2005.
6. Utech M, Brüwer M and Nusrat A: Tight junctions and cell-cell interactions. Methods Mol Biol 341: 185-195, 2006.
7. Angelow S and Yu AS: Claudins and paracellular transport: an update. Curr Opin Nephrol Hypertens 16: 459-464, 2007. (Pubitemid 47254697)
8. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J and Blasig IE: Structure and function of claudins. Biochim Biophys Acta 1778: 631-645, 2008.
9. Singh AB, Sharma A and Dhawan P: Claudin family of proteins and cancer: an overview. J Oncol 2010: 541957, 2010.
10. Turksen K and Troy TC: Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 1816: 73-79, 2011.
11. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001. (Pubitemid 32591662)
12. Vihinen P, Ala-aho R and Kähäri VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5: 203-220, 2005. (Pubitemid 40694861)
13. Gibbs DF, Warner RL, Weiss SJ, Johnson KJ and Varani J: Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 20: 1136-1144, 1999. (Pubitemid 129503231)
14. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004. (Pubitemid 39592897)
15. Uzui H, Harpf A, Liu M, Doherty TM, Shukla A and Chai N: Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106: 3024-3030, 2002. (Pubitemid 35440283)
16. Lambert E, Dasse E, Haye B and Petitfrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49: 187-198, 2004. (Pubitemid 38251351)
17. Cunningham KG, Manson W, Spring FS and Hutchinson SA: Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 166: 949, 1950.
18. Paterson RR: Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69: 1469-1495, 2008.
19. Müller WE, Weiler BE, Charubala R, Pfleiderer W, Leserman L, Sobol RW, Suhadolnik RJ and Schröder HC: Cordycepin analogues of 2′,5′-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry 30: 2027-2033, 1991.
20. Job D, Durand R, Job C and Teissere M: Complex RNA chain elongation kinetics by wheat germ RNA polymerase II. Nucleic Acids Res 12: 3303-3319, 1984.
21. Wu WC, Hsiao JR, Lian YY, Lin CY and Huang BM: The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol 60: 103-111, 2007.
22. Chen LS, Stellrecht CM and Gandhi V: RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br J Haematol 140: 682-691, 2008. (Pubitemid 351300913)
23. Thomadaki H, Tsiapalis CM and Scorilas A: The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemother Pharmacol 61: 703-711, 2008.
24. Chen Y, Chen YC, Lin YT, Huang SH and Wang SM: Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the calcium-calpain- caspase 7-PARP pathway. J Agric Food Chem 58: 11645-11652, 2010.
25. Jeong JW, Jin CY, Park C, Hong SH, Kim GY, Jeong YK, Lee JD, Yoo YH and Choi YH: Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol In Vitro 25: 817-824, 2011.
26. Zhu W, Fu A, Hu J, Wang T, Luo Y, Peng M, Ma Y, Wei Y and Chen L: 5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway. Exp Mol Med 43: 146-152, 2011.
27. Grant-Tschudy KS and Wira CR: Effect of oestradiol on mouse uterine epithelial cell tumour necrosis factor-alpha release is mediated through uterine stromal cells. Immunology 115: 99-107, 2005. (Pubitemid 40593296)
28. Song HY, Ju SM, Goh AR, Kwon DJ, Choi SY and Park J: Suppression of TNF-alpha-induced MMP-9 expression by a cell-permeable superoxide dismutase in keratinocytes. BMB Rep 44: 462-467, 2011.
29. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37: 65-71, 2001.
30. Usami Y, Satake S, Nakayama F, Matsumoto M, Ohnuma K, Komori T, Semba S, Ito A and Yokozaki H: Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 215: 330-339, 2008. (Pubitemid 351956714)
31. Nelson WJ and Nusse R: Convergence of Wnt, β-catenin, and cadherin pathways. Science 303: 1483-1487, 2004. (Pubitemid 38314410)
32. McLachlan RW and Yap AS: Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts. J Mol Med 85: 545-554, 2007. (Pubitemid 46870898)
33. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI and Gupta S: Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121: 1424-1432, 2007. (Pubitemid 47328700)
34. Li N and Neu J: Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells. J Nutr 139: 710-714, 2009.
35. Gitter AH, Bendfeldt K, Schmitz H, Schulzke JD, Bentzel CJ and Fromm M: Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-α. Ann NY Acad Sci 915: 193-203, 2000. (Pubitemid 32059380)
36. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9: 2567-2575, 2003. (Pubitemid 36842098)
37. Agarwal R, D'Souza T and Morin PJ: Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385, 2005. (Pubitemid 41161271)
38. Yoon CH, Kim MJ, Park MJ, Park IC, Hwang SG, An S, Choi YH, Yoon G and Lee SJ: Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCδ) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem 285: 226-233, 2010.
39. Van Itallie CM and Anderson JM: Claudins and epithelial paracellular transport. Annu Rev Physiol 68: 403-429, 2006.
40. Grotegut S, von Schweinitz D, Christofori G and Lehembre F: Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25: 3534-3545, 2006. (Pubitemid 44264864)
41. Samuels Y and Ericson K: Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18: 77-82, 2006. (Pubitemid 43740454)